Increasing evidence showed that the human TP53INP1 plays the role of anti‐oncogene in CRC, and could be regulated by miRNAs as a critical target, including miR‐125b, miR‐524‐5p, and miR‐200a.21, 22, 23, 24. This evidence concerns the gene TP53INP1 and colorectal carcinoma.